highperformr logo

LEO Pharma's Overview

Total employees5042
HeadquartersBallerup
Founded1908

LEO Pharma is a global pharmaceutical company founded in 1908, specializing in medical dermatology. With a strong focus on research and development, LEO Pharma is committed to delivering innovative treatments and solutions for a wide range of skin diseases. The company's mission is to help people achieve healthy skin by advancing the science of dermatology, improving patient care, and providing access to effective therapies worldwide. LEO Pharma's portfolio covers conditions such as psoriasis, eczema (atopic dermatitis), skin infections, and rare skin diseases. Headquartered in Denmark, the company has a significant global presence, with R&D, manufacturing, and commercial operations across numerous countries.

Where is LEO Pharma's Headquarters?

HQ Function

The Ballerup headquarters serves as the central hub for LEO Pharma's global operations, including corporate management, strategic planning, research and development leadership, and global marketing.

Notable Features:

A modern and expansive campus featuring state-of-the-art research laboratories, collaborative office spaces, and employee amenities. The site is designed to foster innovation and cross-functional teamwork.

Work Culture:

LEO Pharma's headquarters fosters a science-driven, patient-centric, and collaborative work environment. It reflects Danish work culture principles, emphasizing work-life balance, employee well-being, integrity, and a passion for innovation in dermatology.

HQ Significance:

The headquarters is pivotal for LEO Pharma's global strategy execution, housing key decision-makers and central R&D functions that drive the company's pipeline and product portfolio in medical dermatology.

Values Reflected in HQ: The headquarters' design, operations, and work environment aim to reflect LEO Pharma's core values: Integrity, Customer Focus, Innovation, Passion, and Adaptability, creating a sustainable and inspiring workplace.

Location:

LEO Pharma has an extensive global footprint, with its products available in more than 130 countries. The company supports a wide range of functions worldwide, including research and development in multiple centers, manufacturing facilities (e.g., in Denmark, France, Ireland), commercial operations and sales & marketing teams in major regions like Europe, North America, Asia-Pacific, and Latin America, as well as global clinical trial management and medical affairs.

Street Address:

Industriparken 55

City:

Ballerup

State/Province:

Capital Region of Denmark

Country:

Denmark

LEO Pharma's Global Presence

Madison, New Jersey, USA

Address: LEO Pharma Inc., 7 Giralda Farms, Madison, NJ 07940, USA

Crucial for serving one of the world's largest pharmaceutical markets, focusing on bringing LEO Pharma's dermatological treatments to patients and healthcare professionals in the United States.

Hurley, Berkshire, United Kingdom

Address: LEO Pharma UK/IE, Horizon, Honey Lane, Hurley, Berkshire, SL6 6RJ, UK

Key hub for one of Europe's significant healthcare markets, ensuring access to LEO Pharma's dermatology solutions for patients in the UK and Ireland.

Paris, France

Address: LEO Pharma France, 2 Rue René Caudron, CS 40070, 78960 Voisins-le-Bretonneux, France

Supports LEO Pharma's presence in continental Europe, delivering dermatological treatments and engaging with the French healthcare system and patient communities.

Buying Intent Signals for LEO Pharma

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of LEO Pharma

As of April 2025, LEO Pharma' leadership includes:

Christophe Bourdon - President and Chief Executive Officer (CEO)
Philip Eickhoff - Executive Vice President, Chief Financial Officer (CFO)
Kreena Dhiman - Executive Vice President, Global Research & Development
Sébastien Cros - Executive Vice President, Region Europe, International & China (EIC)
Brian Hilberdink - Executive Vice President, Region North America

Investors of LEO Pharma

LEO Pharma has been backed by several prominent investors over the years, including:

The LEO Foundation (LEO Fondet)

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits2

LEO Pharma has strategically strengthened its executive leadership over the past 12 months, particularly with key appointments in R&D and Finance. These changes are aimed at driving the company's 2030 strategy focused on innovation and growth in medical dermatology.

Departures

Jörg Möller, Jörg Möller departed from his role as head of Global R&D.
Anders Kronborg, Anders Kronborg stepped down as CFO.

New Appointments:

Kreena Dhiman, Kreena Dhiman appointed as EVP, Global R&D, bringing extensive experience to lead LEO Pharma's innovation pipeline.
Philip Eickhoff, Philip Eickhoff appointed as EVP, CFO, to oversee LEO Pharma's global financial strategy and performance.

Technology (Tech Stack) used by LEO Pharma

Discover the tools LEO Pharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

LEO Pharma Email Formats and Examples

LEO Pharma's standard email format typically combines an employee's first and last name, or initials and last name, with the @leo-pharma.com domain. One of the commonly observed patterns is [firstname].[lastname]@leo-pharma.com.

[firstname].[lastname]@leo-pharma.com

Format

john.doe@leo-pharma.com

Example

90%

Success rate

News and media

LEO Pharma Press ReleaseMay 21, 2024

LEO Pharma and Krystal Biotech Enter Definitive Agreement for Ex-U.S. Commercialization Rights to Investigational Medicine B-VEC for Epidermolysis Bullosa

LEO Pharma A/S and Krystal Biotech, Inc. announced a definitive agreement where LEO Pharma will acquire exclusive rights to commercialize B-VEC (beremagene geperpavec) for Epidermolysis Bullosa (EB) in all markets outside the U.S., while Krystal retains U.S. rights. LEO Pharma will make an upfront payment of $100 million....more

LEO Pharma Press ReleaseFebruary 29, 2024

LEO Pharma Appoints Kreena Dhiman as Executive Vice President for Global Research & Development

LEO Pharma announced the appointment of Kreena Dhiman as its new Executive Vice President for Global Research & Development, effective March 1, 2024. She will lead the company's R&D strategy and efforts to advance its pipeline of innovative dermatology treatments....more

LEO Pharma Press ReleaseFebruary 21, 2024

LEO Pharma Annual Report 2023: Revenue growth of 9% to DKK 11.4 billion

LEO Pharma reported solid performance in 2023 with revenue increasing by 9% (5% in constant exchange rates) to DKK 11.4 billion, primarily driven by its dermatology portfolio. The company also highlighted significant progress in its R&D pipeline....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including LEO Pharma, are just a search away.